复星医药再下一城 投资改制绵阳三甲医院

2017-09-25 半夏 赛柏蓝

复星医药与绵阳市第三人民医院签订投资合作框架协议书,将其改制成为绵阳妇产儿童医院。

9月22日下午,复星医药发布公告,公司控股子公司复星医院投资与绵阳市第三人民医院签订投资合作框架协议书,旨在完成绵阳三院高新分院混合所有制医院建设,将其改制成为绵阳妇产儿童医院。

公告显示,绵阳三院始建于1955年,位于四川省绵阳市,辖游仙区中医医院、御营分院、高新区医院3个分院,占地130亩,是一所以脑系和老年医学为特色的三级甲等医院。

合作双方共同出资设立绵阳妇产儿医院管理有限公司(暂定名),由合资公司建设、管理并运营标的医院。复星医院投资以现金出资,占合资公司80%股权;绵阳三院以高新分院现有场地范围内土地、建筑物、设备等相关实物资产出资,占合资公司20%股权。

此次合作有利于推动复星医药医疗服务业务的发展、推动大健康产业区域的布局。

药企纷纷涉足医院

近年来,各路资本并购医疗机构蔚然成风。笔者通过梳理发现,近年来涉足医院的药企比比皆是。

据不完全统计,近年来,先后有复星医药、海南海药、康美药业、北大医药、信邦制药、三诺生物等医药企业宣布并购医疗机构,部分并购对象还是当地公立医院。

早在2013年10月,复星医药子公司上海医诚医院投资管理有限公司拟出资不超过6.93亿元收购佛山市禅城区中心医院有限公司共计60%的股权。

而在2016年9月6日,复星医药有发布公告称,公司全资子公司上海复星医院投资(集团)有限公司与南华大学附属第二医院签订《投资合作框架协议》,双方将通过整合优势资源、互惠共赢,共同打造现代化医院管理体制和运行模式,并最终实现双方健康医疗产业的做优、做强、做大。

2013年8月,北大医疗并购湖南株洲恺德医院,2014年年初则与北大医学部、北大第六医院合办北京大学心理医院。此后,北大医疗接连并购贵阳二医院和贵阳四医院,规模高达30亿元。

2014年10月,三诺生物宣布出资2900万元,收购慢性病管理单位北京健恒糖尿病医院。该医院创建于1991年,设有糖尿病研究所、糖尿病教育中心。

2013年,康美药业与梅河口市政府签订了医疗合作框架意向书,计划整体收购梅河口市妇幼保健院、友谊医院、中医院三家医院,后续将累计至少投入5亿元。

2015年4月华润集团与淮北市政府签署合作共建市人民医院协议,双方承诺3年内建成人民医院新院区并全面投入运营。

2016年5月23日,恒康医疗公告签署合作框架协议,拟揽入三家兰考医院(兰考县人民医院、兰考堌阳医院、兰考东方医院)改制后有限公司的100%股权,进一步提高公司医疗板块业务规模。

2016年8月5日,济民制药发布公告称,公司拟以股权受让方式取得鄂州二医院有限公司80%股权、并向其增资,投资总额不超过3.6亿元。

2016年11月12日,海南海药以3.4亿正式从武汉钢铁集团手中正式买下了鄂钢医院,双方签署《战略合作(框架)协议》,具有58年历史的鄂钢医院正式加入海南海药,同时实现了国企医院身份的转变。

为什么医院受药企热捧?

有业内专家表示,随着医改推进,药企利润受到了影响,都在寻找新的利润增长点,尤其上市公司收购医院是为了做市值管理,拓展利润增长点。

此外,收购医院其实也是药企拓展业务的方式之一。只要收购一家医院,药企自己的产品就有稳定的销路。

可想而知,以前药品进医院还有医保、药事委员会等审核通过,如果医药企业并购医院后,掌握了经营权、人事权,以后什么药品能进医院,药企不是有了主动权了吗?单单这个利好对于国内众多药企来说,已经是足够大了诱惑,还没算上医院的其他创收。

2013年,中国社会科学院公共政策研究中心主任朱恒鹏在清华大学第三届医药健康论坛上表示,未来3、5年会出现一个医院并购的大潮,并预测未来40%的公立医院将会被收购。看来,这个大潮已经涌来。

可以预见,未来,药企在抢占并购医院的道路上,将会愈演愈烈。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1703917, encodeId=00171e039174f, content=<a href='/topic/show?id=fbe55e240a4' target=_blank style='color:#2F92EE;'>#改制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57240, encryptionId=fbe55e240a4, topicName=改制)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aba030602128, createdName=gdsun, createdTime=Tue Jan 16 11:19:00 CST 2018, time=2018-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1365911, encodeId=af401365911a7, content=<a href='/topic/show?id=468119e04db' target=_blank style='color:#2F92EE;'>#三甲医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19704, encryptionId=468119e04db, topicName=三甲医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Wed Sep 27 00:19:00 CST 2017, time=2017-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409079, encodeId=923314090e9f2, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Sep 27 00:19:00 CST 2017, time=2017-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533372, encodeId=9c7c15333e29e, content=<a href='/topic/show?id=0dec4268035' target=_blank style='color:#2F92EE;'>#复星医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42680, encryptionId=0dec4268035, topicName=复星医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=065812431582, createdName=zhs3886, createdTime=Wed Sep 27 00:19:00 CST 2017, time=2017-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1552376, encodeId=13de15523e663, content=<a href='/topic/show?id=a8d5196997c' target=_blank style='color:#2F92EE;'>#三甲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19699, encryptionId=a8d5196997c, topicName=三甲)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88e914287502, createdName=陈吴1239, createdTime=Wed Sep 27 00:19:00 CST 2017, time=2017-09-27, status=1, ipAttribution=)]
    2018-01-16 gdsun
  2. [GetPortalCommentsPageByObjectIdResponse(id=1703917, encodeId=00171e039174f, content=<a href='/topic/show?id=fbe55e240a4' target=_blank style='color:#2F92EE;'>#改制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57240, encryptionId=fbe55e240a4, topicName=改制)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aba030602128, createdName=gdsun, createdTime=Tue Jan 16 11:19:00 CST 2018, time=2018-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1365911, encodeId=af401365911a7, content=<a href='/topic/show?id=468119e04db' target=_blank style='color:#2F92EE;'>#三甲医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19704, encryptionId=468119e04db, topicName=三甲医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Wed Sep 27 00:19:00 CST 2017, time=2017-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409079, encodeId=923314090e9f2, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Sep 27 00:19:00 CST 2017, time=2017-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533372, encodeId=9c7c15333e29e, content=<a href='/topic/show?id=0dec4268035' target=_blank style='color:#2F92EE;'>#复星医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42680, encryptionId=0dec4268035, topicName=复星医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=065812431582, createdName=zhs3886, createdTime=Wed Sep 27 00:19:00 CST 2017, time=2017-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1552376, encodeId=13de15523e663, content=<a href='/topic/show?id=a8d5196997c' target=_blank style='color:#2F92EE;'>#三甲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19699, encryptionId=a8d5196997c, topicName=三甲)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88e914287502, createdName=陈吴1239, createdTime=Wed Sep 27 00:19:00 CST 2017, time=2017-09-27, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1703917, encodeId=00171e039174f, content=<a href='/topic/show?id=fbe55e240a4' target=_blank style='color:#2F92EE;'>#改制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57240, encryptionId=fbe55e240a4, topicName=改制)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aba030602128, createdName=gdsun, createdTime=Tue Jan 16 11:19:00 CST 2018, time=2018-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1365911, encodeId=af401365911a7, content=<a href='/topic/show?id=468119e04db' target=_blank style='color:#2F92EE;'>#三甲医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19704, encryptionId=468119e04db, topicName=三甲医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Wed Sep 27 00:19:00 CST 2017, time=2017-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409079, encodeId=923314090e9f2, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Sep 27 00:19:00 CST 2017, time=2017-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533372, encodeId=9c7c15333e29e, content=<a href='/topic/show?id=0dec4268035' target=_blank style='color:#2F92EE;'>#复星医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42680, encryptionId=0dec4268035, topicName=复星医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=065812431582, createdName=zhs3886, createdTime=Wed Sep 27 00:19:00 CST 2017, time=2017-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1552376, encodeId=13de15523e663, content=<a href='/topic/show?id=a8d5196997c' target=_blank style='color:#2F92EE;'>#三甲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19699, encryptionId=a8d5196997c, topicName=三甲)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88e914287502, createdName=陈吴1239, createdTime=Wed Sep 27 00:19:00 CST 2017, time=2017-09-27, status=1, ipAttribution=)]
    2017-09-27 cathymary
  4. [GetPortalCommentsPageByObjectIdResponse(id=1703917, encodeId=00171e039174f, content=<a href='/topic/show?id=fbe55e240a4' target=_blank style='color:#2F92EE;'>#改制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57240, encryptionId=fbe55e240a4, topicName=改制)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aba030602128, createdName=gdsun, createdTime=Tue Jan 16 11:19:00 CST 2018, time=2018-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1365911, encodeId=af401365911a7, content=<a href='/topic/show?id=468119e04db' target=_blank style='color:#2F92EE;'>#三甲医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19704, encryptionId=468119e04db, topicName=三甲医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Wed Sep 27 00:19:00 CST 2017, time=2017-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409079, encodeId=923314090e9f2, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Sep 27 00:19:00 CST 2017, time=2017-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533372, encodeId=9c7c15333e29e, content=<a href='/topic/show?id=0dec4268035' target=_blank style='color:#2F92EE;'>#复星医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42680, encryptionId=0dec4268035, topicName=复星医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=065812431582, createdName=zhs3886, createdTime=Wed Sep 27 00:19:00 CST 2017, time=2017-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1552376, encodeId=13de15523e663, content=<a href='/topic/show?id=a8d5196997c' target=_blank style='color:#2F92EE;'>#三甲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19699, encryptionId=a8d5196997c, topicName=三甲)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88e914287502, createdName=陈吴1239, createdTime=Wed Sep 27 00:19:00 CST 2017, time=2017-09-27, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1703917, encodeId=00171e039174f, content=<a href='/topic/show?id=fbe55e240a4' target=_blank style='color:#2F92EE;'>#改制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57240, encryptionId=fbe55e240a4, topicName=改制)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aba030602128, createdName=gdsun, createdTime=Tue Jan 16 11:19:00 CST 2018, time=2018-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1365911, encodeId=af401365911a7, content=<a href='/topic/show?id=468119e04db' target=_blank style='color:#2F92EE;'>#三甲医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19704, encryptionId=468119e04db, topicName=三甲医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Wed Sep 27 00:19:00 CST 2017, time=2017-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409079, encodeId=923314090e9f2, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Sep 27 00:19:00 CST 2017, time=2017-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533372, encodeId=9c7c15333e29e, content=<a href='/topic/show?id=0dec4268035' target=_blank style='color:#2F92EE;'>#复星医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42680, encryptionId=0dec4268035, topicName=复星医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=065812431582, createdName=zhs3886, createdTime=Wed Sep 27 00:19:00 CST 2017, time=2017-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1552376, encodeId=13de15523e663, content=<a href='/topic/show?id=a8d5196997c' target=_blank style='color:#2F92EE;'>#三甲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19699, encryptionId=a8d5196997c, topicName=三甲)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88e914287502, createdName=陈吴1239, createdTime=Wed Sep 27 00:19:00 CST 2017, time=2017-09-27, status=1, ipAttribution=)]
    2017-09-27 陈吴1239

相关资讯

又一家三甲医院,被药企买下!

9月22日下午,复星医药发布公告,公司控股子公司复星医院投资与绵阳市第三人民医院签订投资合作框架协议书,旨在完成绵阳三院高新分院混合所有制医院建设,将其改制成为绵阳妇产儿童医院。

Kite制药成立中国合资公司,与日本第一三共2.5亿美金推进CAR-T药物

随着Kite制药(Kite Pharma)创新性CAR-T药物KTE-C19进入监管机构加速审批的最后阶段,Kite已经寻找了两家合作伙伴以帮助其打入两个重要的亚洲市场。Kite宣布在中国成立合资企业,并与第一三共达成2.5亿美金交易以打入日本市场。 在本次与第一三共的合作中,Kite前期持有5000万美金,并达成2亿美金的阶段性交易。第一三共对Kite接下来三年内即将上报FDA的